In Kenya, where breast cancer remains the most common cancer among women, Mwende Mutiso's journey shows what it means to defy ...

An experimental vaccine targeting aggressive triple-negative breast cancer (TNBC) has shown encouraging early results in ...

Cleveland Clinic researchers are presenting final Phase 1 data from their novel study of a vaccine aimed at preventing triple ...

A new study published in JAMA suggests that risk-based breast cancer screening could be a more effective approach than annual ...

Only 6% of trials for FDA-approved drugs match America's diversity. Analysis reveals how trial location and design choices ...

Black patients were less likely to receive PARP inhibitors, despite having BRCA1/2 testing and positivity rates comparable to White patients, and were at higher risk of death.

Medicare Advantage simplifies health coverage for seniors, but coverage gaps and limited access to Black physicians still pose challenges.

However, many women with BRCA mutations perceive MHT as unsafe, due to concerns about their already elevated breast cancer ...

A mobile health (mHealth) intervention for adolescent and young adult breast cancer survivors that offered tailored support ...

More than one-third of U.S. adults diagnosed with metastatic HER2-negative breast cancer in 2023 did not undergo testing for BRCA mutations, according to a retrospective analysis.Less than half ...

December 12, 2025. Markets now expect the next move in ECB rates will be up - a significant shift from October, wh ...